Recovery act tissue samples and data from various types of cancer for the cancer genome atlas (tcga) program arra::yes::arra

Ended Awarded Last action

Contract number
HHSN261201000052I
Awardee
Awarding agency
Task orders
1 $20,637 obligated

Award facts

Combined order value
$20,637 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 93% used
$22,113.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Cedars-Sinai Medical Center, a nonprofit hospital and academic medical center located in Los Angeles. The $22,113 contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the NCI's efforts related to the American Recovery and Reinvestment Act (ARRA). This work contributes to the TCGA program's goals of comprehensively characterizing the genomic changes involved in cancer. The contract is a single-award indefinite delivery vehicle (IDV) with a potential $500 million ceiling value, awarded in 2023 for the Trans-Omics for Precision Medicine initiative, allowing for future task orders to be placed through September 2033 for providing complex data analysis, integration and management of large-scale genomic and health datasets. The award evaluation considered responses demonstrating the ability to perform such data operations and advance precision medicine efforts for the National Institutes of Health.

The initial $20,636.55 firm fixed-price delivery order under this IDV contract was for the recovery of tissue samples and data from various types of cancer to support the TCGA program. The work was performed in West Hollywood, California, and had a period of performance from June 23, 2010 to September 30, 2014. The contract did not have a set-aside designation.

Task orders

Transactions

Action Obligated Date
Other Administrative Action 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Supplemental Agreement for work within scope 1 · Arra::yes::arra recovery act tissue samples and data from various types of cancer for the cancer genome atlas (tcga) program $0
Original award $0

Quick answers

Who was awarded contract HHSN261201000052I?

HHSN261201000052I was awarded to Cedars-Sinai Medical Center by National Cancer Institute (National Institutes of Health) on June 23, 2010.

How much is contract HHSN261201000052I worth?

Orders under HHSN261201000052I have obligated $20,637. HHSN261201000052I's own ceiling is $22,113.

How many orders have been placed under contract HHSN261201000052I?

1 order has been placed under HHSN261201000052I, the latest on June 23, 2010.

Who can order from contract HHSN261201000052I?

HHSN261201000052I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201000052I part of a contract vehicle?

Yes. HHSN261201000052I is part of NCI Cancer Genome Atlas Program Tissue Purchase.

Was contract HHSN261201000052I competed?

The extent of competition for HHSN261201000052I was competed under sap. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV